NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders. Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships, Workshop Summary. Washington (DC): National Academies Press (US); 2008.

Cover of Neuroscience Biomarkers and Biosignatures

Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships, Workshop Summary.

Show details

Forum on Neuroscience and Nervous System Disorders

ALAN LESHNER (Chair), American Association for the Advancement of Science, Washington, D.C.

HUDA AKIL, University of Michigan, Ann Arbor

MARC BARLOW, GE Healthcare, Inc., Bucks, United Kingdom

DANIEL BURCH, CeNeRx Biopharma, Research Triangle Park, North Carolina

DENNIS CHOI, Emory University, Atlanta, Georgia

TIMOTHY COETZEE, National Multiple Sclerosis Society, New York

DAVID COHEN, Columbia University, Society for Neuroscience representative, New York

RICHARD FRANK, GE Healthcare, Inc., Princeton, New Jersey

RICHARD HODES, National Institute on Aging, Bethesda, Maryland

STEVEN HYMAN, Harvard University, Cambridge, Massachusetts

JUDY ILLES, University of British Columbia, Vancouver, Canada

THOMAS INSEL, National Institute of Mental Health, Bethesda, Maryland

STORY LANDIS, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland

TING-KAI LI, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland

MICHAL OBERDORFER, NIH Blueprint for Neuroscience Research, Bethesda, Maryland

KATHIE OLSEN, National Science Foundation, Arlington, Virginia

ATUL PANDE, GlaxoSmithKline, Inc., Research Triangle Park, North Carolina

STEVEN PAUL, Eli Lilly and Company, Indianapolis, Indiana

WILLIAM POTTER, Merck Research Laboratories, Inc., North Wales, Pennsylvania

PAUL SIEVING, National Eye Institute, Bethesda, Maryland

RAE SILVER, Columbia University, New York

WILLIAM THIES, Alzheimer’s Association, Chicago, Illinois

ROY TWYMAN, Johnson & Johnson Pharmaceutical Research and Development, LLC, Titusville, New Jersey

NORA VOLKOW, National Institute on Drug Abuse, Bethesda, Maryland

FRANK YOCCA, AstraZeneca Pharmaceuticals, Wilmington, Delaware

CHRISTIAN ZIMMERMAN, Neuroscience Associates, Boise, Idaho

STEVIN ZORN, Pfizer Global Research and Development, Ann Arbor, Michigan

IOM Staff

BRUCE ALTEVOGT, Project Director

SARAH HANSON, Senior Program Associate

LORA TAYLOR, Senior Project Assistant


IOM Anniversary Fellow

LISA BARCELLOS, University of California, Berkeley

Copyright © 2008, National Academy of Sciences.
Bookshelf ID: NBK53119


  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (1.5M)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...